MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$743,294K
(25.06%↑ Y/Y)
Other current assets
$28,566K
(-57.81%↓ Y/Y)
Other receivables
$24,649K
(-49.87%↓ Y/Y)
Prepaid data assets
$11,742K
Restricted cash
$4,594K
(50.87%↑ Y/Y)
Total current assets
$812,845K
(13.80%↑ Y/Y)
Intangible assets, net
$309,903K
(-7.73%↓ Y/Y)
Goodwill
$162,158K
(8.92%↑ Y/Y)
Property and equipment,
net
$103,931K
(-26.32%↓ Y/Y)
Operating lease
right-of-use assets
$45,339K
(-31.18%↓ Y/Y)
Financing lease
right-of-use assets
$20,210K
(-23.08%↓ Y/Y)
Other assets,
non-current
$12,754K
(44.52%↑ Y/Y)
Restricted cash,
non-current
$6,033K
(7.18%↑ Y/Y)
Deferred tax assets
$957K
(-50.52%↓ Y/Y)
Total assets
$1,474,130K
(1.76%↑ Y/Y)
Total liabilities and
stockholders equity
$1,474,130K
(1.76%↑ Y/Y)
Total stockholders
equity
$1,130,865K
(9.29%↑ Y/Y)
Total liabilities
$343,265K
(-17.05%↓ Y/Y)
Accumulated deficit
-$2,076,002K
(-45.04%↓ Y/Y)
Additional paid-in capital
$3,170,145K
(28.15%↑ Y/Y)
Total current
liabilities
$147,707K
(-21.21%↓ Y/Y)
Unearned revenue,
non-current
$114,012K
(-4.00%↓ Y/Y)
Operating lease
liabilities, non-current
$46,647K
(-30.64%↓ Y/Y)
Deferred tax liabilities
$23,255K
(40.30%↑ Y/Y)
Notes payable and
financing lease...
$9,564K
(-49.72%↓ Y/Y)
Other liabilities,
non-current
$2,080K
(-56.04%↓ Y/Y)
Accumulated other
comprehensive income (loss)
$36,717K
(580.78%↑ Y/Y)
Common stock, 0.00001
par value...
$5K
(25.00%↑ Y/Y)
Accrued expenses and
other liabilities
$70,230K
(-14.22%↓ Y/Y)
Unearned revenue
$37,605K
(-39.12%↓ Y/Y)
Accounts payable
$18,118K
(-16.17%↓ Y/Y)
Operating lease
liabilities
$12,663K
(-8.21%↓ Y/Y)
Notes payable and
financing lease...
$9,091K
(7.91%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)